Researchers launch confidential helpline, 833-EMS-INTX, for Texas first responders to find help for substance use disorder

First responders in Texas can now call a confidential helpline to seek treatment for substance use and mental health disorders through a new clinical research program at The University of Texas Health Science Center at Houston (UTHealth). The Heroes Helpline comes at a time when first responders are serving on the front lines of the COVID-19 pandemic.

Rutgers Expert Available to Comment on COVID-19 Neurological Effects in Seniors

Dr. XinQi Dong, MD, MPH, director of the Institute for Health, Health Care Policy and Aging Research at Rutgers University-New Brunswick, is available to comment on the importance of further research into neurological effects of COVID-19 that may be related…

Experts at UTHealth successfully treat severe case of COVID-19 in 3-week-old infant

In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The case was published April 22 in the New England Journal of Medicine.

U MD School of Medicine Researchers Test Experimental Therapy to Prevent COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have begun testing the effectiveness of hydroxychloroquine as a therapy to prevent infection and symptoms in individuals who have been exposed to COVID-19-positive individuals. The trial is significant because it focuses on preventing COVID-19 and does not involve individuals who are ill with infection but rather healthy individuals who have been exposed.

Rutgers Supplies Hospitals with PPE to Battle COVID-19

During the coronavirus pandemic, health care professionals worldwide are facing shortages of personal protection equipment (PPE). But faculty, students and staff from across Rutgers are coming together to produce face shields and intubation boxes themselves with off-the-shelf materials to help relieve the PPE shortage at area hospitals.

The PALM Trial honored with the Society for Clinical Trials’ prestigious David Sackett Trial of the Year Award for 2020

Each year since 2008, SCT has awarded the David Sackett Trial of the Year Award to a randomized, controlled trial published (either electronically or in print) in the previous calendar year. The 2020 recipient is Pamoja Tulinde Maisha (PALM [“Together Save Lives”] in the Kiswahili language) trial.

Penn Medicine Launches COVID-19 Convalescent Plasma Study

Convalescent plasma therapy for COVID-19 patients — an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection — is the focus of a new two-part research initiative at Penn Medicine. Researchers will first collect plasma from people who have recovered from their infection under a donor research protocol. The second part involves conducting clinical trials to test the safety and efficacy of giving that plasma to moderately and severely ill hospitalized patients.

Rural dwellers who value self-reliance don’t take COVID-19 seriously

People in rural areas who place heavy importance on self-reliance and define health by their ability to work might take the COVID-19 pandemic less seriously, says Pamela Stewart Fahs, professor and expert in rural nursing at Binghamton University, State University…

DePaul University experts available to discuss recovery, life after the COVID-19 pandemic

Recovery. Reentry. Reopen. Return. A new normal. Faculty experts at DePaul University are available for news media interviews about what comes next — after the COVID-19 pandemic. Does the world return to normal or will there be fundamental changes to how we live our lives, work, and travel; and how we are governed?

UAB among first in the U.S. to offer clinical trial for the treatment of patients with severe COVID-19 using nitric oxide

iNO has been used for the treatment of failing lungs, but it was also found to have antiviral properties against coronaviruses.The University of Alabama at Birmingham has been selected to begin enrolling patients in an international study assessing the use of inhaled nitric oxide (iNO) to improve outcomes for COVID-19 patients with severely damaged lungs.

Tufts University offers tools, guidance to encourage universities to help relieve strain on nation’s healthcare system

In its continuing efforts to encourage colleges and universities across the country to share resources and facilities with local hospitals and communities to relieve unprecedented strain on the healthcare system caused by COVID-19, Tufts University today announced it is making available tools and guidance to help facilitate relationships between schools and their local healthcare providers and government authorities.

Tufts to Make Residence Halls Available to Local Hospitals and Host Cities

In partnership with local health-care providers and its host communities, Tufts University today announced it will make its residence halls available to house medical personnel, first responders, and patients, including those recovering from COVID-19, in an effort to help contain the spread of the virus as local hospitals prepare for a surge of cases that threatens to overwhelm their capacity.

Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19

Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited to cancer patients is exploring hydroxychloroquine and azithromycin.

Engineers share designs for 3D printed ventilator adapters to help during coronavirus pandemic

Engineers at Binghamton University, State University of New York have made their designs for 3D printed ventilator adapters available to the public to help during the coronavirus pandemic.

Individuals taking class of steroid medications at high risk for COVID-19

Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

FDA Approves First Plasma Therapy for Houston Methodist COVID-19 Patient

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside over the weekend as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the United States, with more than 100,000 Americans sick from the virus.

Kelley School initiative sparks ideas from around world to address problems from coronavirus

Among the millions of Americans working from home, a group of Indiana University Kelley School of Business professors created a worldwide movement to seek solutions for problems arising from the novel coronavirus. Their “Idea Sprint Weekend Against COVID-19” initiative was organized in just three days and led to the development of several new social initiatives addressing issues related to the COVID-19 crisis, including a shortage of surgical masks, grocery stockouts, displaced workers and online educational challenges that students are facing across the country.

The global supply chain is breaking under the COVID-19 pandemic

From medical equipment shortages to panic-buying, the links in supply chains are breaking but will serve as valuable learning lessons for the future, said Ednilson Bernardes, professor and program coordinator of the Global Supply Chain Management program, West Virginia University…

COVID-19 big picture: For many years, Pinar Keskinocak has studied how society and the nation handle pandemics.

For many years, Pinar Keskinocak has studied how pandemics spread through the nation, how they overburden health care systems, and how they diminish the supply of medications, thus worsening the pandemic. All this also spins off additional medical crises. She…